Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Pfister

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
Cancer Journal (Sudbury, Mass.)|June 29, 2006
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancerYungpo Bernard Su, Andrew J Vickers, Michael J Zelefsky, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2011
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic reviewEric J Sherman, Su Hsien Lim, Alan L Ho, et al.
Journal of Surgical Oncology|June 2, 2017
Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer DatabaseBenjamin R Roman, Shrujal S Baxi, Jennifer R Cracchiolo, et al.
Investigational New Drugs|May 11, 2002
A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neckDavid G Pfister, John McCaffrey, Andrew J Zahalsky, et al.
Cancer|June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancerEric J Sherman, Lara A Dunn, Alan L Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trialDavid G Pfister, Barrie R Cassileth, Gary E Deng, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2011
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PETJacobus F A Jansen, Heiko Schöder, Nancy Y Lee, et al.
Human Pathology|August 21, 2020
Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomasSnjezana Dogan, Paolo Cotzia, Ryan N Ptashkin, et al.
Thyroid : Official Journal of the American Thyroid Association|May 6, 2022
A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid CancerNancy Y Lee, Nadeem Riaz, Vanessa Wu, et al.
The Lancet. Oncology|December 20, 2011
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trialNancy Y Lee, Qiang Zhang, David G Pfister, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Cancer Journal (Sudbury, Mass.)|June 29, 2006
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancerYungpo Bernard Su, Andrew J Vickers, Michael J Zelefsky, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2011
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic reviewEric J Sherman, Su Hsien Lim, Alan L Ho, et al.
Journal of Surgical Oncology|June 2, 2017
Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer DatabaseBenjamin R Roman, Shrujal S Baxi, Jennifer R Cracchiolo, et al.
Investigational New Drugs|May 11, 2002
A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neckDavid G Pfister, John McCaffrey, Andrew J Zahalsky, et al.
Cancer|June 30, 2017
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancerEric J Sherman, Lara A Dunn, Alan L Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trialDavid G Pfister, Barrie R Cassileth, Gary E Deng, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2011
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PETJacobus F A Jansen, Heiko Schöder, Nancy Y Lee, et al.
Human Pathology|August 21, 2020
Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomasSnjezana Dogan, Paolo Cotzia, Ryan N Ptashkin, et al.
Thyroid : Official Journal of the American Thyroid Association|May 6, 2022
A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid CancerNancy Y Lee, Nadeem Riaz, Vanessa Wu, et al.
The Lancet. Oncology|December 20, 2011
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trialNancy Y Lee, Qiang Zhang, David G Pfister, et al.
Pageof 17